BBOT short interest
BridgeBio Oncology Therapeutics Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 3,374,885 |
|---|---|
| Change vs prior report | -221,094 (-6.2%) |
| Change over six months | +40.9% |
| Days to cover | 5.40 (sector: 3.78) |
| Average daily volume | 624,657 |
| Rank in Healthcare | #380 of 922 by days to cover |
BBOT short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 3,374,885 | -6.2% | 5.40 | 624,657 |
| 2026-09-15 | 3,595,979 | -41.9% | 4.36 | 824,822 |
| 2026-08-31 | 6,193,538 | +6.6% | 20.77 | 298,249 |
| 2026-08-14 | 5,808,214 | -0.3% | 24.80 | 234,207 |
| 2026-07-31 | 5,826,298 | +2.4% | 20.77 | 280,563 |
| 2026-07-15 | 5,688,384 | +9.1% | 12.60 | 451,434 |
| 2026-06-30 | 5,212,731 | +32.3% | 7.18 | 726,372 |
| 2026-06-15 | 3,940,239 | +1.9% | 15.66 | 251,629 |
| 2026-05-29 | 3,866,368 | +18.1% | 8.33 | 464,305 |
| 2026-05-15 | 3,275,227 | -1.4% | 10.12 | 323,701 |
| 2026-04-30 | 3,320,560 | +2.6% | 6.06 | 547,983 |
| 2026-04-15 | 3,237,088 | +35.2% | 7.25 | 446,350 |
| 2026-03-31 | 2,394,870 | +6.1% | 18.95 | 126,396 |
| 2026-03-13 | 2,256,471 | -3.1% | 11.68 | 193,141 |
| 2026-02-27 | 2,328,433 | -0.6% | 7.80 | 298,380 |
| 2026-02-13 | 2,341,952 | +8.4% | 8.32 | 281,614 |
| 2026-01-30 | 2,160,487 | -1.1% | 8.66 | 249,377 |
| 2026-01-15 | 2,184,668 | +18.4% | 4.37 | 499,934 |
| 2025-12-31 | 1,845,729 | +23.1% | 11.02 | 167,512 |
| 2025-12-15 | 1,499,664 | +32.8% | 7.18 | 208,953 |
| 2025-11-28 | 1,129,317 | +15.6% | 8.44 | 133,778 |
| 2025-11-14 | 976,866 | +19.8% | 8.28 | 117,954 |
| 2025-10-31 | 815,670 | +6.9% | 5.60 | 145,781 |
| 2025-10-15 | 763,171 | -31.0% | 3.52 | 216,551 |
| 2025-09-30 | 1,106,527 | +1317.2% | 2.10 | 527,697 |
import finzdata as yf
yf.Ticker("BBOT").short_interest # every report since 2017
yf.Client().short_interest(["BBOT"], start="2018-01-01")Healthcare short interest · BBOT price history · Who owns BBOT · All short interest